FUNDAMENTALS |
MarketCap: |
6.03 mill
|
EPS: |
-0.650
|
P/E: |
-0.140
|
Earnings Date: |
May 08, 2024 |
SharesOutstanding: |
66.78 mill
|
Avg Daily Volume: |
0.377 mill
|
RATING
2024-04-25 |
B-
|
Sell
|
RATINGS |
Rating CashFlow: |
Strong Sell
|
|
Return On Equity: |
Strong Sell
|
|
Return On Asset: |
Sell
|
|
DE: |
Strong Buy
|
|
P/E: |
Neutral
|
|
Price To Book: |
Sell
|
|
QUARTER GROWTHS |
|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 |
Revenue | | | | | | |
Gr.Profit | | | | | | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | | | |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE -0.140 | sector: PE 15.43
|
PE RATIO: COMPANY / INDUSTRY |
0.00x
|
Company: PE -0.140 | industry: PE 87.83
|
DISCOUNTED CASH FLOW VALUE |
$-0.0069
(-107.63%)
$-0.0972
|
Date: 2024-04-25
|
Expected Trading Range (DAY) |
$ 0.0683 - 0.112
( +/- 24.36%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2024-04-15 | Guo Chris | Sell | 481 | Common Stock |
2024-03-26 | Chen Roy T | Sell | 2 625 | Common Stock |
2024-03-26 | Bergheim Bjarne | Sell | 11 493 | Common Stock |
2024-03-15 | Guo Chris | Sell | 0 | Common Stock |
2024-03-15 | Guo Chris | Sell | 38 355 | Stock Option |
INSIDER POWER |
77.53
|
Last
100 transactions |
Buy:
5 157 721 | Sell:
775 843 |
Forecast:
13:52 - $0.0890
Live Trading Signals (every 1 min)
Forecast
1: 12:22 - $0.0910
Forecast 2: 13:12 - $0.0890
Forecast 3: 13:52 - $0.0890
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
MACD |
|
Volume Signals |
Price |
$0.0903 (-3.53% )
|
Volume |
0.0191 mill
|
Avg. Vol. |
0.377 mill
|
% of Avg. Vol |
5.06 %
|
Signal 1: |
|
Signal 2: |
|
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SONX
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California.